Emily's Entourage
Maria P. Limberis serves as the Vice President of Research at Spirovant Sciences, Inc. since December 2020. Limberis is also an Associate Editor for the Journal of Human Gene Therapy and a member of the Scientific Advisory Board for Emily's Entourage. Prior experience includes various roles at the University of Pennsylvania, where Limberis was a Research Associate Professor of Medicine and held multiple directorial positions, including leading the Program of Excellence in Cystic Fibrosis. Limberis also contributed significantly to the Gene Therapy Program, serving as Research Director and Executive Director. Initial experience includes a researcher role at Boehringer Mannheim, S.A. Limberis earned a PhD in Molecular Biology from the University of Adelaide and a BSc (Hons) in Biochemistry from Liverpool John Moores University.
This person is not in the org chart
This person is not in any teams
Emily's Entourage
Emily's Entourage (EE) is an innovative 501(c)3 foundation that funds research for new treatments and a cure for individuals in the final 10% of the cystic fibrosis (CF) community that do not benefit from existing mutation-targeted therapies, including those with nonsense mutations. CF is a fatal genetic disease primarily affecting the lungs and digestive system. Founded by Emily Kramer-Golinkoff, a woman with advanced stage CF, and her devoted friends and family, the organization has been featured in national media, including the New York Times, STAT, CNN, People, and more. Since 2011, Emily’s Entourage has awarded millions of dollars in research grants, launched a now-acquired CF gene therapy company, developed a patient registry and clinical trial matchmaking program to accelerate clinical trial recruitment, and led worldwide efforts to drive high-impact research and drug development. The organization’s work is particularly critical now as revolutionary breakthroughs are available for roughly 90% of the CF population, but those in the outlying 10% that unfortunately do not benefit from these major advances. The work of EE is laser-focused on changing that — and doing it fast, so nobody is left behind